33 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01333 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | M14 | Melanoma | IC50 : 5 μM |
| dbacp01385 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | KM12 | Colon cancer | IC50 : 4 - 5 μM |
| dbacp02020 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | M14 | Skin cancer | IC50 : 15.1 µg/ml |
| dbacp02043 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | KM12 | Colon cancer | IC50 : 12 µg/ml |
| dbacp02078 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | M14 | Not specified | IC50 : 15.1 µg/ml |
| dbacp02101 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | KM12 | Not specified | IC50 : 12 µg/ml |
| dbacp02273 | Camel | KWKLFKKIGAVLKVL | Ceropin-Melittin hybrid | Cell swelling and rupture of the plasma membrane | MTT/MTS assay | WM1158 | Skin cancer | LC50 : 4.1 µM |
| dbacp02644 | Defensin-like protein (Sesquin) | KTCENLADTY | Yard-Long bean | Anti-proliferative action | MTT assay | M1 | Breast cancer | MIC : 0.125 μg/ml |
| dbacp03711 | Laxaphycin A | Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG | Terrestrial blue-green alga or the marine cyanobacterium | Not specified | Cell viability assay | CEM-VM1 | Leukemia cancer | No inhibition at 4 µM |
| dbacp03714 | Laxaphycin B | A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu | Terrestrial blue-green alga or the marine cyanobacterium | Not specified | Cell viability assay | CEM-VM1 | Leukemia cancer | 44% inhibition at 1 µM |
| dbacp03717 | Laxaphycin B | A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu | Terrestrial blue-green alga or the marine cyanobacterium | Not specified | Cell viability assay | CEM-VM1 | Leukemia cancer | 40% inhibition at 1 µM |
| dbacp05038 | P18 | KWKLFKKIPKFLHLAKKF | Bovine lactoferrin (Lf-B) | Necrosis; Cell membrane rupture | MTT/MTS assay | M14 | Skin cancer | 92.2 ± 1.02% cell viability at 10 µM |
| dbacp05039 | P18 | KWKLFKKIPKFLHLAKKF | Synthetic peptide | Necrosis; Cell membrane rupture | MTT/MTS assay | M14 | Skin cancer | 71.1 ± 2.84% cell viability at 20 µM |
| dbacp05040 | P18 | KWKLFKKIPKFLHLAKKF | Synthetic peptide | Necrosis; Cell membrane rupture | MTT/MTS assay | M14 | Skin cancer | 50 ± 3.09% cell viability at 40 µM |
| dbacp05041 | P18 | KWKLFKKIPKFLHLAKKF | Synthetic peptide | Necrosis; Cell membrane rupture | MTT/MTS assay | M14 | Skin cancer | 31.5 ± 1.49% cell viability at 60 µM |
| dbacp05042 | P18 | KWKLFKKIPKFLHLAKKF | Synthetic peptide | Necrosis; Cell membrane rupture | MTT/MTS assay | M14 | Skin cancer | 13.8 ± 1.44% cell viability at 80 µM |
| dbacp07580 | R-DIM-P-LF11 | FQWQRNIRKVRPRVKRINRQWQF | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 20.9 ± 3.9 μM |
| dbacp07583 | R-DIM-P-LF11-322 | PFWRIRIRRPRRIRIRWFP | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 4.7 ± 0.2 μM |
| dbacp07586 | DIM-LF11-322 | PFWRIRIRRPFWRIRIRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 4.6 ± 0.1 μM |
| dbacp07589 | R-DIM-P-LF11-215 | FWRIRIRRPRRIRIRWF | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 4.6 ± 0.1 μM |
| dbacp07592 | R-DIM-P-LF11-334 | PWRIRIRRPRRIRIWP | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 5.0 ± 0.1 μM |
| dbacp07595 | R-DIM-LF11-334-LF11-334 | PWRIRIRRRRIRIRWPPWRIRIRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 3.6 ± 0.7 μM |
| dbacp07598 | DIM-LF11-339 | RRWFWRRRRWFWRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 3.8 ± 0.3 μM |
| dbacp07805 | cT1 | KWCFRVCYRGICYRRCRG | Synthetic | Not Available | Resazurin dye assay | WM164 | Skin Cancer | CC50 = 2.7 ± 0.1 µM |
| dbacp07810 | [R/K]cT1 | KWCFKVCYKGICYKKCKG | Synthetic | Not Available | Resazurin dye assay | WM164 | Skin Cancer | CC50 = 4.3 ± 0.3 µM |
| dbacp07816 | [W2S]cT1 | KSCFRVCYRGICYRRCRG | Synthetic | Not Available | Resazurin dye assay | WM164 | Skin Cancer | CC50 = 3.9 ± 0.2 µM |
| dbacp07822 | [Y8S-I11S]cT1 | KWCFRVCSRGSCYRRCRG | Synthetic | Not Available | Resazurin dye assay | WM164 | Skin Cancer | CC50 = 28.2 ± 2.0 µM |
| dbacp07827 | [R14S]cT1 | KWCFRVCYRGICYSRCRG | Synthetic | Not Available | Resazurin dye assay | WM164 | Skin Cancer | CC50 = 2.7 ± 0.1 µM |
| dbacp07832 | [R17S]cT1 | KWCFRVCYRGICYRRCSG | Synthetic | Not Available | Resazurin dye assay | WM164 | Skin Cancer | CC50 = 1.8 ± 0.1 µM |
| dbacp07836 | [R9S-R14S-R17S]cT1 | KWCFRVCYSGICYSRCSG | Synthetic | Not Available | Resazurin dye assay | WM164 | Skin Cancer | CC50 = 11.1 ± 0.9 µM |
| dbacp07840 | [G18K]cT1 | KWCFRVCYRGICYRRCRK | Synthetic | Not Available | Resazurin dye assay | WM164 | Skin Cancer | CC50 = 2.7 ± 0.2 µM |
| dbacp07845 | [I11F-G18K]cT1 | KWCFRVCYRGFCYRRCRK | Synthetic | Not Available | Resazurin dye assay | WM164 | Skin Cancer | CC50 = 2.9 ± 0.2 µM |
| dbacp07947 | IL13Rα2 D1 peptide | GSETWKTIITKN | Synthetic | IL13Rα2 blockade inhibits cancer metastasis | MTT assay | KM12SM | Colorectal Cancer | inhibited IL13-stimulated cell adhesion |